Company Report
Last edited 4 years ago
PerformanceCommunity EngagementCommunity Endorsement
Performance (71m)
-0.4% pa
Followed by
17
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Bull Case
stale
Added 4 years ago

2 Positive Announcements in 2 days.

Everyone knows that penthrox works, and is safe, as an emergency pain reliever, MVP is slowly grinding through the beauracracy that is each countries regulators.

23 October 2019 Penthrox launch in Italy. this is good news as Italy is one of the Big 4 European countries.

I have held my valuation at $6 to wait and see what traction it can get in Italy.

#Industry/competitors
stale
Last edited 5 years ago

11 July 2019,

this is a make or break year, the approvals are in place, not to see if the market really exists.

 

 

 

MVP is an Australian company delivering emergency medical solutions dedicated to improving patient outcomes. MVP is a leader in emergency pain relief and respiratory products. The Company manufactures Penthrox®, a fast acting trauma & emergency pain relief product. It is used in Australian Hospitals including Emergency Departments, Australian Ambulance Services, the Australian Defence Force, Sports Medicine and for analgesia during short surgical procedures such as Dental and Cosmetic surgery as well as in other medical applications. MVP is expanding internationally and manufactures a range of world-leading Asthma respiratory devices.